Pharmaceuticals Financial News

Sanofi India Ltd.(up 3.83 per cent), Gland Pharma Ltd.(up 2.96 per cent), Mankind Pharma Ltd.(up 2.63 per cent), Glenmark Pharmaceuticals Ltd.(up 1.55 per cent) and Ipca Laboratories Ltd.(up 1.49 per cent) were among the top gainers.

Dalmia Bharat Sugar and Industries Ltd.(up 5.69%), Magadh Sugar & Energy Ltd.(up 5.53%), KCP Sugar & Industries Corporation Ltd.(up 5.00%), Simbhaoli Sugars Ltd.(up 4.09%), Balrampur Chini Mills Ltd.(up 3.14%), Avadh Sugar & Energy Ltd.(up 2.77%), Shree Renuka Sugars Ltd.(up 2.40%), Mawana Sugars Ltd.(up 2.22%), Vishwaraj Sugar Industries Ltd.(up 2.04%) and Bajaj Hindusthan Sugar Ltd.(up 1.31%) stood among the top gainers.

This column is part of the eighth annual Heard on the Street stock picking series. Pharmaceutical firm Grifols is wounded. The bleeding can be stopped. Between the time it first listed on Spain’s stock market in 2006 and the onset of the Covid-19 crisis in 2020, the Barcelona-based company outperformed the S&P 500 almost fivefold thanks to its role as a supplier of blood-plasma-based medicines and its geographical diversification.

Shares of Divi's Laboratories Ltd.(up 1.45 per cent), Cipla Ltd.(up 1.24 per cent), Alkem Laboratories Ltd.(up 1.13 per cent), Lupin Ltd.(up 1.09 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.89 per cent) ended the day as top gainers in the pack.

Ukraine on Friday inked four agreements and resolved to enhance their cooperation in a range of key areas including defence, trade, pharmaceuticals, green energy and education with Prime Minister Narendra Modi and Ukrainian President Volodymyr Zelenskyy reaffirming commitment to further develop the bilateral ties. In their wide-ranging talks, the two leaders also expressed mutual interest in working towards elevating the ties from a comprehensive partnership to a strategic one. Underlining the importance of defence cooperation, Modi and Zelenskyy agreed to work towards facilitating a stronger relationship in the sector including through joint collaborations and partnerships for manufacturing of military hardware in India. Modi arrived in Kyiv this morning on a special train on the first-ever visit to Ukraine by an Indian prime minister after it became independent in 1991.

United States has emerged as India's top trading partner in January-June this year, while the country has recorded its highest trade deficit of $41.6 billion with China during the period, think tank Global Trade Research Initiative (GTRI) said Friday. India exports goods to 239 countries of which 126 countries showed positive growth in exports. Imports from Russia grew to $34.4 billion from $30.8 billion, a 11.65% increase. It also said the country's merchandise exports rose 5.41% to $230.51 billion during the first half of 2024, led by sectors like iron ore, pharmaceuticals, precious stones, basmati rice, chemicals, and smartphones.

The NSE Nifty index ended the session 11.66 points up at 24823.15, while BSE Sensex rose 33.02 points to 81086.21.

pharmacy of the world," its pharmaceutical giants are not just keeping pace—they're setting the pace. With the industry projected to leap from a value of $40 billion in 2021 to $130 billion by 2030, the stage is set for unprecedented growth. But as these companies scale new heights, they must also navigate a complex landscape of regulatory hurdles, global competition, and supply chain risks.

Japan's Nikkei share average rose in early trade on Friday, with pharma shares rallying for a second session, although gains were limited as tech stocks followed their U.S. peers lower. Japanese exporter-heavy equity markets also got some broad support from a weaker yen versus the dollar. However, the outlook for the currency pair looks murky, with investors watching Bank of Japan Governor Kazuo Ueda's testimony in parliament after last month's surprise rate hike.

An explosion triggered a fire at a pharmaceutical plant in southern India, killing at least 18 workers

New Delhi: The Drugs Controller General of India (DCGI) is considering issuing and renewing licences only to those pharmaceutical firms that can prove they follow good manufacturing practices. The move—the first such—assumes significance given the growing size of the Indian pharmaceutical industry, currently at $65 billion, and the crisis of confidence faced by it. Good Manufacturing Practices, or GMP, prescribed in Schedule M of the Drugs and Cosmetics Rules, 1945, set the standards for pharma companies on the quality of raw materials, methods, machines, processes, personnel, facility and environment, among other things.

Brookfield Asset Management Inc. is asking banks to line up about €9.5 billion (US$10.6 billion) of debt for its potential take-private deal for Spanish pharmaceutical producer Grifols SA, according to people with knowledge of the matter.

TOKYO : Japan’s balance of trade fell back into the red in July, with the yen’s recent appreciation dimming the outlook for the nation’s exports. Japan posted a trade deficit of 621.8 billion yen for July, equivalent to $4.28 billion. That followed a 224 billion yen surplus in June, Ministry of Finance data showed Wednesday, and compared with the 359.1 billion yen deficit expected by economists polled by data provider Quick.

Ipca Laboratories is gearing up to make a strong return to the US generics business, with regulatory issues over its manufacturing facilities now behind, and integration of Unichem. The Mumbai-based drug maker is aiming for consolidated US revenue of $200 million (₹1,675 crore) in the next 12-18 months, managing director Ajit Kumar Jain told ET in an interview. The US business of Unichem clocked around $120 million revenue in FY24. While Ipca doesn't give a separate break up of its US revenue, it is quite small. «The US...we were there, but because of regulatory issues it took us some time to get those (regulatory) clearances; now all our plants have cleared,» Jain said.

economic agenda at a campaign rally in North Carolina, a Republican swing state, focusing on lowering costs, and hoping to usher in what she called an 'opportunity economy' — 'Everyone, regardless of who they are or where they start, has an opportunity to build wealth for themselves and their children.' Harris' proposed economic plan follows up Bidenomics. Except that this time around, Harris — and Trump, in his own way — has embraced the idea of a strong federal government that would use its authority to manipulate markets to create a more robust and wealthy economy. However, neither Harris not Trump has, till date, presented a thorough policy framework. Harris has called for a reduction in the price of food, housing, medicine and other living expenses. A large portion of Joe Biden's last presidential budget — and brief re-election campaign — are being expanded upon by Harris. The strategy calls for significant tax hikes on corporations and high earners to support middle-class and low-income workers. Simultaneously, it offers substantial tax advantages to businesses involved in activities that Democrats believe yield significant economic benefits, such as building affordable housing, or developing technologies required to combat global warming.

H100 graphic processing units (GPUs) procured by Hiranandani Group’s Mumbai-headquartered Yotta Data Services from American chip maker Nvidia are used by companies abroad and only the rest are used by Indian companies, said Yotta Data Services chief executive Sunil Gupta. He told ET that this was because of a more advanced artificial intelligence (AI) ecosystem in the West that leads to heightened demand for GPUs. By November the company plans to deploy an additional 8,000 GPUs, he said. “Last November we placed an order for 16,384 H100 GPUs. From a medium to long-term scale, 16,384 may not be enough for India. We deployed the first phase of 4,096 chips. By March-April, we had got all the chips. Around seven to eight weeks back, we commissioned all of them,” Gupta told ET in an interview on August 13.

Department of Pharmaceuticals (DoP) has started discussions with local manufacturers of rubber gloves to look into their complaints about poor quality products that are getting dumped in the country. Domestic glovemakers alleged that gloves from countries like Thailand, Malaysia and China are being dumped in India under different non-medical product codes. The department has been contemplating issuance of quality control orders in consultation with the Bureau of Indian Standards and has already invited comments from stakeholders on the matter.

Taxpayers are expected to save billions after the Biden administration inked deals with pharmaceutical companies to knock down the list prices for 10 of Medicare’s costliest drugs

Shares of Glenmark Pharmaceuticals Ltd.(up 5.01 per cent), Biocon Ltd.(up 4.06 per cent), Mankind Pharma Ltd.(up 3.83 per cent), Abbott India Ltd.(up 3.24 per cent) and Zydus Lifesciences Ltd.(up 1.46 per cent) ended the day as top gainers in the pack.

India-EU trade mustn’t stumble on digital sovereignty "The EU is advocating for stronger intellectual property protections, which India is cautious about due to concerns over generic medicines. Additionally, the EU is pressing for sustainability and labour standards in the agreement, but India is worried about their impact on its domestic regulations and industries," said trade analyst Ajay Srivastava, who is the founder of Global Trade Research Initiative (GTRI), a think tank.

J B Chemicals & Pharmaceuticals Ltd.(up 1.87 per cent), Natco Pharma Ltd.(up 1.59 per cent), Glenmark Pharmaceuticals Ltd.(up 1.53 per cent), Lupin Ltd.(up 1.17 per cent) and Granules India Ltd.(up 0.95 per cent) were among the top gainers.